✦ LIBER ✦

Immunogenicity and safety of a virosomal hepatitis A vaccine in HIV-positive patients

✍ Scribed by L. Loutan; P. Bovier; C. Herzog

Book ID: 116959890
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 96 KB
Volume: 25
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2007.06.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and safety of a pediatric

Immunogenicity and safety of a pediatric dose virosomal hepatitis A vaccine in Thai HIV-infected children

✍ Rachanee Saksawad; Sasithorn Likitnukul; Boonyarat Warachit; Orrawadee Hanvivatv 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Immunogenicity and safety of a virosomal

Immunogenicity and safety of a virosomal influenza vaccine in HIV-infected children

✍ GV Zuccotti; C Cucchi; D Sala; M Giovannini 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Immunogenicity and Safety of a Virosomal

Immunogenicity and Safety of a Virosomal Hepatitis A Vaccine (Epaxal®) in the Elderly

✍ Valérie D’Acremont; Christian Herzog; Blaise Genton 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Immunogenicity and safety of a virosomal

Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal®) in healthy toddlers and children in Chile

✍ S Riedemann; G Reinhardt; H Ibarra; GG Frösner 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Immunogenicity and safety of an inactiva

Immunogenicity and safety of an inactivated hepatitis a vaccine in anti-HIV positive and negative homosexual men

✍ Dr. Georg Hess; Ralf Clemens; Ulrich Bienzle; Christian Schönfeld; Birgit Schunc 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

The immunogenicity, reactogenicity, and safety of an inactivated hepatitis A vaccine were assessed in anti-HIV positive homosexual men. Fourteen anti-HIV positive (group 1) and 20 anti-HIV negative (group 2) men received vaccine (containing 720 ELISA units of hepatitis A antigen per dose) intramuscu

Long-term immunogenicity of an inactivat

Long-term immunogenicity of an inactivated virosome hepatitis A vaccine

✍ P.A. Bovier; J. Bock; L. Loutan; T. Farinelli; R. Glueck; C. Herzog 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

## Abstract The aim of this study was to predict the long‐term protection induced after immunisation with inactivated, aluminium‐free virosome hepatitis A vaccine. The study population consisted of adult volunteers enrolled in four different clinical trials. Lower 95% confidence interval limits and